Current Report Filing (8-k)
December 14 2022 - 04:56PM
Edgar (US Regulatory)
0000040545false00000405452022-12-092022-12-090000040545us-gaap:CommonStockMember2022-12-092022-12-090000040545ge:A1.250NotesDue2023Member2022-12-092022-12-090000040545ge:A0.875NotesDue2025Member2022-12-092022-12-090000040545ge:A1.875NotesDue2027Member2022-12-092022-12-090000040545ge:A1.500NotesDue2029Member2022-12-092022-12-090000040545ge:A7.5GuaranteedSubordinatedNotesDue2035Member2022-12-092022-12-090000040545ge:A2.125NotesDue2037Member2022-12-092022-12-09
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of
1934
Date of Report (Date of earliest event reported)
December 9, 2022
General Electric Company
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
New York |
|
001-00035 |
|
14-0689340 |
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
|
|
|
|
|
|
5 Necco Street |
Boston, |
MA |
|
|
|
02210 |
(Address of principal executive offices) |
|
|
|
(Zip Code) |
|
|
|
|
|
|
(Registrant’s telephone number, including area code)
(617) 443-3000
_______________________________________________
(Former name or former address, if changed since last
report.)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instructions
A.2. below):
|
|
|
|
|
|
|
|
|
☐ |
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
|
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b)) |
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c)) |
|
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
|
|
|
|
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common stock, par value $0.01 per share
|
GE
|
New York Stock Exchange
|
1.250% Notes due 2023
|
GE 23E
|
New York Stock Exchange
|
0.875% Notes due 2025
|
GE 25
|
New York Stock Exchange
|
1.875% Notes due 2027
|
GE 27E
|
New York Stock Exchange
|
1.500% Notes due 2029
|
GE 29
|
New York Stock Exchange
|
7 1/2% Guaranteed Subordinated Notes due 2035
|
GE /35
|
New York Stock Exchange
|
2.125% Notes due 2037
|
GE 37
|
New York Stock Exchange
|
|
|
|
|
|
|
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§ 240.12b-2 of this chapter). |
|
|
Emerging growth company |
☐ |
|
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards pursuant to Section 13(a) of the Exchange
Act. |
☐ |
Item 5.02
Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers
On December 9, 2022, the Board of Directors (the “GE Board”) of
General Electric Company (“GE”) and GE directors Risa
Lavizzo-Mourey and Tomislav Mihaljevic agreed that Dr.
Lavizzo-Mourey and Dr. Mihaljevic would resign from the GE Board
effective January 3, 2023, in connection with GE’s planned spin-off
of its healthcare business, GE HealthCare Holding LLC (“GE
HealthCare”), after market close that day.
As previously announced, Dr. Lavizzo-Mourey and Dr. Mihaljevic will
join the GE HealthCare board of directors upon completion of the
spin-off.
Current GE directors H. Lawrence Culp, Jr. and Catherine Lesjak,
who are also joining the GE HealthCare board of directors, will
remain on the GE Board as well.
Forward-looking statements.
This document contains “forward-looking statements”—that is,
statements related to future, not past, events. These
forward-looking statements often address GE’s expected future
business and financial performance and financial condition, and
often contain words such as “expect,” “anticipate,” “intend,”
“plan,” “believe,” “seek,” “see,” “will,” “would,” “estimate,”
“forecast,” “target,” “preliminary,” or “range.” Forward-looking
statements by their nature address matters that are, to different
degrees, uncertain, and are subject to risks, uncertainties and
assumptions. For GE, particular areas where risks or uncertainties
could cause GE’s actual results to be materially different than
those expressed in GE’s forward-looking statements include: GE’s
success in executing and completing asset dispositions or other
transactions, including GE’s plans to pursue the GE HealthCare
spin-off and the spin-off its portfolio of energy businesses that
are planned to be combined as GE Vernova (Renewable Energy, Power,
Digital and Energy Financial Services), and sales or other
dispositions of GE’s equity interests in Baker Hughes Company and
AerCap Holdings N.V. and GE’s expected equity interest in GE
Healthcare after its spin-off, the timing for such transactions,
the ability to satisfy any applicable pre-conditions, and the
expected proceeds, consideration and benefits to GE; changes in
macroeconomic and market conditions and market volatility,
including impacts related to the COVID-19 pandemic, risk of
recession, inflation, supply chain constraints or disruptions,
rising interest rates, oil, natural gas and other commodity prices
and exchange rates, and the impact of such changes and volatility
on GE’s business operations, financial results and financial
position; and GE’s de-leveraging and capital allocation plans,
including with respect to actions to reduce its indebtedness, the
capital structures of the three public companies that GE plans to
form from its businesses, the timing and amount of dividends, share
repurchases, organic investments, and other priorities; and other
factors that are described in the “Risk Factors” section of GE’s
Annual Report on Form 10-K for the year ended December 31, 2021 and
its Quarterly Report on Form 10-Q for the quarter ended March 31,
2022, as such descriptions may be updated or amended in any future
reports that GE files with the SEC. These or other uncertainties
may cause GE’s actual future results to be materially different
than those expressed in its forward-looking statements. GE does not
undertake to update its forward-looking statements.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly
authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General Electric Company |
|
|
|
(Registrant) |
|
|
|
|
|
Date: December 14, 2022
|
|
/s/ Brandon Smith |
|
|
|
Brandon Smith
Vice President, Chief Corporate, Securities & Finance
Counsel
|
|
General Electric (NYSE:GE)
Historical Stock Chart
From May 2023 to Jun 2023
General Electric (NYSE:GE)
Historical Stock Chart
From Jun 2022 to Jun 2023